- Trump struck deals with 16 drug companies. But they're still raising prices this year NPR
- US pharma MFN and tariff dynamics: What EU and UK leaders need to know pharmaphorum
- Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox CSIS | Center for Strategic and International Studies
- 2026 U.S drug pricing outlook: 'MFN' is the future BioCentury
- The Push for Lower US Drug Prices Uses Bad Logic Bloomberg.com
Need a Custom App Built?
Let's discuss your project and bring your ideas to life.
Contact Me Today →